Dom Conde, Ha Kung Wong, Damien Dombrowski, Erin Austin, and Monica Chou represented Melinta Therapeutics against Nexus Pharmaceuticals in the Northern District of Illinois in an ANDA litigation regarding Nexus’s proposed generic version of Melinta’s injectable Minocin© antibiotic. The court ruled in Melinta’s favor on all issues. The court found that both of Melinta’s patents were valid over Nexus’s numerous invalidity assertions, that Nexus infringed all of the asserted claims, and that Nexus would induce infringement of the method of treatment claims. As a result, Venable obtained a judgment permanently enjoining Nexus from manufacturing or selling its infringing generic ANDA product in the United States until the patents expire in May 2031. Also assisting at trial were Joann Behan and Launa Willingham.